Treatment of hemolytic anemia with danazol

Details Treatment of hemolytic anemia with danazol Treatment of hemolytic anemia with danazol

1986-12-01

1989-06-06

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514814, A61K 3158

Patent

active

048372129

ABSTRACT:
Danazol, a known androgen, is used to (1) correct immune abnormalities associated with hemotologic disorders or (2) treating immune disorders associated with depressed T helper cells, in the invention disclosed.

REFERENCES:
patent: 3135743 (1964-06-01), Clinton et al.

Affiliated with

Also associated with

Rating

Treatment of hemolytic anemia with danazol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hemolytic anemia with danazol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hemolytic anemia with danazol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-40663